These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23795351)

  • 1. [Molecular classification and markers of malignant melanoma].
    Tímár J; Hársing J; Somlai B
    Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
    Vrotsos E; Alexis J
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
    Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
    Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
    Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
    Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
    PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma Risk and Melanocyte Biology.
    Bertrand JU; Steingrimsson E; Jouenne F; Bressac-de Paillerets B; Larue L
    Acta Derm Venereol; 2020 Jun; 100(11):adv00139. PubMed ID: 32346747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New prognostic factors and developing therapy of cutaneous melanoma.
    Vihinen PP; Pyrhönen SO; Kähäri VM
    Ann Med; 2003; 35(2):66-78. PubMed ID: 12795336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Egberts F; Hitschler WN; Weichenthal M; Hauschild A
    Melanoma Res; 2009 Feb; 19(1):31-5. PubMed ID: 19104452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum markers for melanoma].
    Ugurel S
    Hautarzt; 2005 Feb; 56(2):173-84; 185-6. PubMed ID: 15657726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel genes associated with malignant melanoma but not benign melanocytic lesions.
    Talantov D; Mazumder A; Yu JX; Briggs T; Jiang Y; Backus J; Atkins D; Wang Y
    Clin Cancer Res; 2005 Oct; 11(20):7234-42. PubMed ID: 16243793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.
    Curiel-Olmo S; García-Castaño A; Vidal R; Pisonero H; Varela I; León-Castillo A; Trillo E; González-Vela C; García-Diaz N; Almaraz C; Moreno T; Cereceda L; Madureira R; Martinez N; Ortiz-Romero P; Valdizán E; Piris MA; Vaqué JP
    Oncotarget; 2015 Sep; 6(28):25452-65. PubMed ID: 26327537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients.
    Domingo-Domènech J; Castel T; Auge JM; Garcia-Albeniz XA; Conill C; Puig S; Vilella R; Matas J; Malvehy J; Gascón P; Mellado B; Molina R
    Tumour Biol; 2007; 28(5):264-72. PubMed ID: 17962723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine melanotic cutaneous lesions and lymph nodes: immunohistochemical differentiation of melanocytes and melanophages.
    Grossi AB; Hyttel P; Jensen HE; Leifsson PS
    Vet Pathol; 2015 Jan; 52(1):83-91. PubMed ID: 24503437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.